journal article·2020-12-14Open access

Recombinant Silk Fibroin Crystalline Regions as Biomaterial Alternatives to the Full-Length Protein

Zifan Wang, Bogdan A. Serban, Monica A. Serban

Abstract

Silk fibroin is a natural polymer with a unique repetitive structure that translates to extraordinary properties in terms of processability and mechanical properties. The Bombyx mori silk has a molecular weight of ∼415 kDa and consists of a light chain and a heavy chain. Its heavy chain is organized into 12 crystalline domains. Each of these crystalline domains contains subdomains of ∼70 amino acid containing blocks. It is well understood that the heavy chain of the protein is responsible for its processing versatility and excellent mechanical properties; however, the need for the high number of monomeric repeating units is unclear, and the individual properties of crystalline regions compared to those of the full-length protein are not understood. The work described herein assessed the possibility of using recombinant crystalline regions as alternative biomaterials for applications such as tissue adhesives. Our results indicate that while the two tested substructures do not fully recapitulate the native silk fibroin's properties, they appear to be a suitable alternative for the production of silk-based medical adhesives.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Silk-based biomaterials and applications · Biochemical and Structural Characterization · Nanofabrication and Lithography Techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Center for Biomolecular Structure and Dynamics, and Division of Biological Sciences, University of Montana, Missoula, Montana 59812, United States

Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, Montana 59812, United States

Department of Chemistry and Biochemistry, University of Montana, Missoula, Montana 59812, United States

Funding

National Institute of General Medical Sciences

References (28)

Show source-provided references
1. 10.1016/S0142-9612(02)00353-810.1016/S0142-9612(02)00353-8 ↗
2. 10.1016/S0142-9612(02)00156-410.1016/S0142-9612(02)00156-4 ↗
3. 10.1016/j.actbio.2015.04.00410.1016/j.actbio.2015.04.004 ↗
4. 10.1002/adhm.20180046510.1002/adhm.201800465 ↗
5. 10.1111/nyas.1288610.1111/nyas.12886 ↗
6. 10.1021/bm034546010.1021/bm0345460 ↗
7. 10.1016/j.biomaterials.2006.01.02210.1016/j.biomaterials.2006.01.022 ↗
8. 10.1038/nprot.2011.37910.1038/nprot.2011.379 ↗
9. 10.1016/j.progpolymsci.2007.05.01310.1016/j.progpolymsci.2007.05.013 ↗
10. 10.1039/C8TB00607E10.1039/C8TB00607E ↗
11. 10.1126/science.118893610.1126/science.1188936 ↗
12. 10.1002/adma.20170463610.1002/adma.201704636 ↗
13. 10.1016/j.copbio.2012.03.01310.1016/j.copbio.2012.03.013 ↗
14. 10.1016/B978-0-12-407679-2.00004-110.1016/B978-0-12-407679-2.00004-1 ↗
15. 10.1038/srep3647310.1038/srep36473 ↗
16. 10.1016/0022-2836(89)90295-710.1016/0022-2836(89)90295-7 ↗
17. 10.1002/prot.107810.1002/prot.1078 ↗
18. 10.1021/bm050294m10.1021/bm050294m ↗
19. Gage L. P. · J. Biol. Chem. · 1980 · 255 · 944410.1016/S0021-9258(19)70582-1 ↗
20. 10.1093/nar/28.12.241310.1093/nar/28.12.2413 ↗
21. Serban M. A. · 2012 · 1
22. 10.1021/bm049487k10.1021/bm049487k ↗
23. 10.1002/mrc.133710.1002/mrc.1337 ↗
24. 10.1021/acsbiomaterials.8b0054410.1021/acsbiomaterials.8b00544 ↗
25. 10.1021/acsbiomaterials.9b0101410.1021/acsbiomaterials.9b01014 ↗
26. 10.1006/abio.2000.488010.1006/abio.2000.4880 ↗
27. 10.1021/jp951561t10.1021/jp951561t ↗
28. 10.1089/wound.2014.056110.1089/wound.2014.0561 ↗